本頁面由Tiger Trade Technology Pte. Ltd.提供服務

FibroBiologics

1.42
-0.0201-1.40%
成交量:6.23萬
成交額:8.84萬
市值:945.40萬
市盈率:-0.30
高:1.45
開:1.44
低:1.39
收:1.44
52周最高:12.40
52周最低:0.6201
股本:665.82萬
流通股本:584.31萬
量比:2.12
換手率:1.07%
股息:- -
股息率:- -
每股收益(TTM):-4.7656
每股收益(LYR):-8.3501
淨資產收益率:-660.08%
總資產收益率:-95.77%
市淨率:2.04
市盈率(LYR):-0.17

資料載入中...

2024/06/27

重要事件披露

Form 8-K - Current report
2024/06/22

SEC問詢函

Form CORRESP - Correspondence
2024/06/22

SEC問詢函

Form CORRESP - Correspondence
2024/06/19

SEC問詢函

Form CORRESP - Correspondence
2024/06/18

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/06/04

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/15

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/15

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/26

重要事件披露

Form 8-K - Current report
2024/04/26

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/03/28

SEC問詢函

Form CORRESP - Correspondence
2024/03/27

SEC問詢函

Form CORRESP - Correspondence
2024/03/26

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/16

SEC問詢函

Form CORRESP - Correspondence
2024/03/15

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/20

重要事件披露

Form 8-K - Current report
2024/02/14

重要事件披露

Form 8-K - Current report
2024/02/12

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933